- Home
- TKC vs LIVN Comparison
TKC vs LIVN Comparison
Compare TKC & LIVN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TKC | LIVN |
|---|---|---|
| Founded | 1993 | 1987 |
| Country | Turkey | United Kingdom |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
| Sector | Telecommunications | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.7B | 4.3B |
| IPO Year | 2001 | 2015 |
Fundamental Metrics
Financial Performance| Metric | TKC | LIVN |
|---|---|---|
| Price | $5.18 | $76.61 |
| Analyst Decision | | Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $72.43 |
| AVG Volume (30 Days) | ★ 2.1M | 545.1K |
| Earning Date | 05-08-2026 | 05-06-2026 |
| Dividend Yield | ★ 2.52% | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | N/A | ★ 2.33 |
| Revenue | N/A | N/A |
| Revenue This Year | $31.20 | $9.79 |
| Revenue Next Year | $24.27 | $6.63 |
| P/E Ratio | ★ $26.98 | $32.38 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $4.82 | $48.82 |
| 52 Week High | $7.18 | $85.76 |
Technical Indicators
Market Signals| Indicator | TKC | LIVN |
|---|---|---|
| Relative Strength Index (RSI) | 46.02 | 42.70 |
| Support Level | $4.86 | $74.99 |
| Resistance Level | $5.43 | $82.39 |
| Average True Range (ATR) | 0.09 | 2.09 |
| MACD | 0.01 | -0.33 |
| Stochastic Oscillator | 59.02 | 34.91 |
Price Performance
Historical ComparisonAbout TKC Turkcell Iletisim Hizmetleri AS
Turkcell Iletisim Hizmetleri AS provides mobile telephone services in Turkey. The firm's services portfolio includes mobile and fixed voice, data, TV, and digital services over its network. The firm also operates in the Turkish Republic of Northern Cyprus, Belarus, the Netherlands, and Ukraine. It has three main reportable segments: Turkcell Turkiye, Techfin, and Other. The Turkcell Turkiye segment, which derives the majority of revenue, comprises mainly telecommunication and technology services activities.
About LIVN LivaNova PLC
UK-based LivaNova was born of a combination of Cyberonics in the US and Sorin in Italy. The medical-device firm is primarily focused on cardiopulmonary solutions (with heart-lung machines and oxygenation equipment) as well as neuromodulation devices for treatment-resistant epilepsy and depression. Following the merger, LivaNova divested its cardiac rhythm management, heart valve, and extracorporeal membrane oxygenation businesses. It derives approximately half of its revenue from the US market, another 21% from Europe, and the remainder from the rest of the world.